Athletics: Momentous sprint at the 2156 Olympics?
暂无分享，去创建一个
Andrew D. Yates | Yvonne R Stephens | A. Nicholson | M. Stratton | P. Futreal | R. Wooster | P. Stephens | S. O'meara | S. Edkins | J. Teague | A. Menzies | G. Bignell | D. Louis | C. Cooper | B. Weber | C. Greenman | A. Butler | K. Raine | H. Davies | B. Teh | S. Forbes | R. Shepherd | Raffaella Smith | G. Chenevix-Trench | E. Dicks | M. Blow | L. Looijenga | S. Leung | S. Yuen | S. West | S. Widaa | M. Pierotti | A. Parker | C. Stevens | A. Flanagan | Chris J Hunter | J. Cole | K. Gray | K. Halliday | K. Hills | J. Perry | Alexandra Small | C. Tofts | J. Varian | P. Goldstraw | F. Brasseur | M. Knowles | R. Foster | V. Kosmidou | R. Lugg | Andy Barthorpe | L. Brackenbury | Ken Edwards | R. Petty | B. Malkowicz | Oliver Clarke | Angus Dike | A. Drozd | Lewis Ratford | G. Harris | C. Hunter | Rebecca Shepherd | Leendert H. J. Looijenga | Anja C. Drozd | Barbara Weber | Simon I. Hay | Michael R. Stratton | Suet Y. Leung | Siu T. Yuen | Kelly Halliday | Calli Tofts | David N. Louis | Andrew G. Nicholson | Colin S. Cooper | Adrienne M. Flanagan | Vivian Kosmidou | Colin S Cooper | Colin S. Cooper | Andrew J. Tatem | Carlos A. Guerra | Peter M. Atkinson
[1] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[2] F. Hirsch,et al. The role of HER2/neu expression and trastuzumab in non-small cell lung cancer. , 2004, Seminars in oncology.
[3] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[4] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[5] R. Rosell. Toward customized trastuzumab in HER-2/neu-overexpressing non-small-cell lung cancers. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] C. Sawyers. Opportunities and challenges in the development of kinase inhibitor therapy for cancer. , 2003, Genes & development.
[7] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.